Entity Common Stock, Shares Outstanding of Dianthus Therapeutics, Inc. /DE/ from 31 Jul 2018 to 04 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2018 to 04 Mar 2026.
  • Dianthus Therapeutics, Inc. /DE/ Entity Common Stock, Shares Outstanding for the quarter ending 04 Mar 2026 was 44,471,094, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 44,471,094 +12,345,915 +38% 04 Mar 2026 10-K 09 Mar 2026 2025 FY
Q3 2025 42,876,015 +13,279,050 +45% 03 Nov 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 32,188,345 +2,834,025 +9.7% 06 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 32,125,179 +2,778,419 +9.5% 07 Mar 2025 10-K 11 Mar 2025 2024 FY
Q3 2024 29,596,965 +14,779,203 +100% 05 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 29,354,320 -31,310,377 -52% 06 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 29,346,760 -31,302,061 -52% 14 Mar 2024 10-K 21 Mar 2024 2023 FY
Q3 2023 14,817,762 -45,737,758 -76% 09 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 60,664,697 +1,774,211 +3% 31 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 60,648,821 +1,849,664 +3.1% 31 Mar 2023 10-K/A 01 May 2023 2022 FY
Q4 2022 60,639,909 +1,840,752 +3.1% 31 Jan 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 60,555,520 +1,778,249 +3% 31 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 58,890,486 +323,213 +0.55% 31 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 58,799,157 +10,188,498 +21% 30 Apr 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 58,799,157 +10,243,022 +21% 31 Jan 2022 10-K 08 Mar 2022 2021 FY
Q3 2021 58,777,271 +10,472,290 +22% 31 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 58,567,273 +10,314,549 +21% 31 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 48,610,659 +9,126,318 +23% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 48,556,135 +9,228,732 +23% 31 Jan 2021 10-K 03 Mar 2021 2020 FY
Q3 2020 48,304,981 +9,315,464 +24% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 48,252,724 +9,485,432 +24% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 39,484,341 +5,830,979 +17% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 39,327,403 31 Jan 2020 10-K 03 Mar 2020 2019 FY
Q3 2019 38,989,517 +5,837,978 +18% 31 Oct 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 38,767,292 +5,822,557 +18% 31 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 33,653,362 30 Apr 2019 10-Q 09 May 2019 2019 Q1
Q3 2018 33,151,539 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 32,944,735 31 Jul 2018 10-Q 09 Aug 2018 2018 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.